WHODrug Global Chinese meets increasing local and international regulatory requirements for the use of standardised drug data in clinical trials and drug safety monitoring.

Pharmacovigilance has officially become one of the main initiatives of the CSDR with the creation of a dedicated committee, who held their first plenary meeting in April this year.

A major event in China this year shone the spotlight on the value of international – and interpersonal – collaborations in driving pharmacovigilance forward.

A group of Chinese scientists has launched the “Inquiring Drug Safety (iDS)” service, an online platform with a new approach to co-creating and sharing drug safety information.